ICD-10-PCS Codes

• 1 3E0C304 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO EYE, PERCUTANEOUS APPROACH)

• 2 3E0C305 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO EYE, PERCUTANEOUS APPROACH)

• 3 3E0C30M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO EYE, PERCUTANEOUS APPROACH)

• 4 3E0C328 (INTRODUCTION OF OXAZOLIDINONES INTO EYE, PERCUTANEOUS APPROACH)

• 5 3E0C329 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO EYE, PERCUTANEOUS APPROACH)

• 6 3E0C33Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO EYE, PERCUTANEOUS APPROACH)

• 7 3E0C3BZ (INTRODUCTION OF ANESTHETIC AGENT INTO EYE, PERCUTANEOUS APPROACH)

• 8 3E0C3GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO EYE, PERCUTANEOUS APPROACH)

• 9 3E0C3HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO EYE, PERCUTANEOUS APPROACH)

• 10 3E0C3KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO EYE, PERCUTANEOUS APPROACH)

• 11 3E0C3MZ (INTRODUCTION OF PIGMENT INTO EYE, PERCUTANEOUS APPROACH)

• 12 3E0C3NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO EYE, PERCUTANEOUS APPROACH)

• 13 3E0C3SF (INTRODUCTION OF OTHER GAS INTO EYE, PERCUTANEOUS APPROACH)

• 14 3E0C3TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO EYE, PERCUTANEOUS APPROACH)

• 15 3E0C704 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 16 3E0C705 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 17 3E0C70M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 18 3E0C728 (INTRODUCTION OF OXAZOLIDINONES INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 19 3E0C729 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 20 3E0C73Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 21 3E0C7BZ (INTRODUCTION OF ANESTHETIC AGENT INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 22 3E0C7GC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 23 3E0C7HZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 24 3E0C7KZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 25 3E0C7MZ (INTRODUCTION OF PIGMENT INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 26 3E0C7NZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 27 3E0C7SF (INTRODUCTION OF OTHER GAS INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 28 3E0C7TZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO EYE, VIA NATURAL OR ARTIFICIAL OPENING)

• 29 3E0CX04 (INTRODUCTION OF LIQUID BRACHYTHERAPY RADIOISOTOPE INTO EYE, EXTERNAL APPROACH)

• 30 3E0CX05 (INTRODUCTION OF OTHER ANTINEOPLASTIC INTO EYE, EXTERNAL APPROACH)

• 31 3E0CX0M (INTRODUCTION OF ANTINEOPLASTIC, MONOCLONAL ANTIBODY, INTO EYE, EXTERNAL APPROACH)

• 32 3E0CX28 (INTRODUCTION OF OXAZOLIDINONES INTO EYE, EXTERNAL APPROACH)

• 33 3E0CX29 (INTRODUCTION OF OTHER ANTI-INFECTIVE INTO EYE, EXTERNAL APPROACH)

• 34 3E0CX3Z (INTRODUCTION OF ANTI-INFLAMMATORY INTO EYE, EXTERNAL APPROACH)

• 35 3E0CXBZ (INTRODUCTION OF ANESTHETIC AGENT INTO EYE, EXTERNAL APPROACH)

• 36 3E0CXGC (INTRODUCTION OF OTHER THERAPEUTIC SUBSTANCE INTO EYE, EXTERNAL APPROACH)

• 37 3E0CXHZ (INTRODUCTION OF RADIOACTIVE SUBSTANCE INTO EYE, EXTERNAL APPROACH)

• 38 3E0CXKZ (INTRODUCTION OF OTHER DIAGNOSTIC SUBSTANCE INTO EYE, EXTERNAL APPROACH)

• 39 3E0CXMZ (INTRODUCTION OF PIGMENT INTO EYE, EXTERNAL APPROACH)

• 40 3E0CXNZ (INTRODUCTION OF ANALGESICS, HYPNOTICS, SEDATIVES INTO EYE, EXTERNAL APPROACH)

• 41 3E0CXSF (INTRODUCTION OF OTHER GAS INTO EYE, EXTERNAL APPROACH)

• 42 3E0CXTZ (INTRODUCTION OF DESTRUCTIVE AGENT INTO EYE, EXTERNAL APPROACH)